Raphael Pharmaceutical Inc.
Raphael Pharmaceutical Inc. (RAPH) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 4 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Nov 25, 2023 involved a transaction of 150,000 shares valued at $60.0K.
RAPH Insider Activity Summary
Who Is Buying RAPH Stock?
No significant insider buying has been recorded for RAPH in the recent period.
Who Is Selling RAPH Stock?
No significant insider selling has been recorded for RAPH in the recent period.
Is Raphael Pharmaceutical Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RAPH is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
RAPH Frequently Asked Questions
Understanding RAPH Insider Activity
Insider trading at Raphael Pharmaceutical Inc. (RAPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading RAPH stock, having executed 4 transactions in the past 90 days. The most active insider is Yehuda Eliya (Executive), who has made 1 transactions totaling $60.0K.
Related Tools
Track Raphael Pharmaceutical Inc. Insider Activity
Get notified when executives and directors at RAPH file new Form 4 transactions